ACXP - Acurx Pharmaceuticals LLC - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

ACXP is currently covered by 1 analysts with an average price target of $11. This is a potential upside of $10.06 (1070.21%) from yesterday's end of day stock price of $0.94.

Acurx Pharmaceuticals LLC's activity chart (see below) currently has 11 price targets and 27 ratings on display. The stock rating distribution of ACXP is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 40% of the time, taking 281.6 days on average.

Highest price target for ACXP is $11, Lowest price target is $11, average price target is $11.

Most recent stock forecast was given by MATTHEW KELLER from HC WAINWRIGHT. First documented stock forecast 28-Nov-2021.

Best performing analysts who are covering ACXP - Acurx Pharmaceuticals LLC:

Ed Arce Jason Mccarthy Matthew Keller

Currently out of the existing stock ratings of ACXP, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-Aug-2025

$11

$9.97 (967.96%)

4 days ago
(11-Nov-2026)

Buy Since 19-Dec-2022

1 years 7 months 28 days ago
(19-Mar-2025)

2/2 (100%)

$-30.2 (-71.56%)

555

Buy Since 29-Nov-2021

$10

3 years 1 months 4 days ago
(12-Oct-2023)

2/2 (100%)

$-71.6 (-87.75%)

853

Show more analysts

Please expand the browser size to see the chart

What is ACXP (Acurx Pharmaceuticals LLC) average time for price targets to be met?

On average it took 282 days for the stock forecasts to be reached, with an average price target met ratio of 40%.

Which analyst most recently updated their price target on ACXP (Acurx Pharmaceuticals LLC)?

Matthew Keller

Which analyst has the lowest performance score on ACXP (Acurx Pharmaceuticals LLC) with a proven track record?

MATTHEW KELLER

Which analyst has the most public recommendations on ACXP (Acurx Pharmaceuticals LLC)?

Matthew Keller has 4 price targets and 3 ratings on ACXP

Which analyst is the currently most bullish on ACXP (Acurx Pharmaceuticals LLC)?

Jason Mccarthy with the highest potential upside of $198.97

Which analyst is the currently most reserved on ACXP (Acurx Pharmaceuticals LLC)?

Ed Arce with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?